Molecular and Translational Oncology Research
分子和转化肿瘤学研究
基本信息
- 批准号:9280411
- 负责人:
- 金额:$ 27.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-07-01 至 2022-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
ABSTRACT
The past decade, an explosion of research and technological achievements in molecular oncology and genomics have
offered an unprecedented opportunity to transform patient care. This shift in the traditional cancer research paradigm,
demands for more sophisticated skills to be acquired by cancer scientists. We are requesting support via a new T32
training grant for the research training of four postdoctoral fellows in Molecular and Translational Oncology Research
(MTOR) at Weill Cornell Medicine (WCM). WCM will provide funding for an additional fifth training slot. The
objective of this program is to recruit the best possible candidates with a solid foundation in basic science and train
them in molecular and translational oncology so that they can apply their knowledge to address important clinically
unmet needs in the prevention, diagnosis, and treatment of cancer patients. MTOR trainees will receive program
support for two years during which they will follow a structured and rigorous postdoctoral training path. The MTOR
program is a joint effort of 17 outstanding WCM preceptors and co-mentors, and a dense network of clinical
collaborators, who are international leaders in their respective fields. Trainees will further profit from the leveraging
of institutional resources such as the Sandra and Edward Meyer Cancer Center and Weill Cornell's Clinical and
Translational Science Center (CTSC). MTOR's highly personalized training plan will include 1) individual
development plans and customized workplans; 2) rigorous translationally focused research training; 3) hands-on
experience in cutting-edge methodologies; and 4) a comprehensive curriculum of innovative core and ancillary skill
acquisition workshops, including writing, leadership, communication, and entrepreneurial perspectives. We anticipate
a pool of at least 300 candidates. We have assembled an outstanding roster of external and internal advisory committee
members with the mandate to evaluate the program and provide specific recommendations to improve its efficiency.
MTOR has a strong diversity focus and through its rigorous, structured and highly personalized curriculum, seeks to
train the future leaders in translational cancer research in the USA.
摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHN BLENIS其他文献
JOHN BLENIS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHN BLENIS', 18)}}的其他基金
The role of NAGK cysteine deprotonation in nutrient stress and cancer progression
NAGK 半胱氨酸去质子化在营养应激和癌症进展中的作用
- 批准号:
10652823 - 财政年份:2023
- 资助金额:
$ 27.23万 - 项目类别:
Molecular and biochemical basis of Lymphangioleiomyomatosis
淋巴管平滑肌瘤病的分子和生化基础
- 批准号:
8788716 - 财政年份:2014
- 资助金额:
$ 27.23万 - 项目类别:
Molecular and biochemical basis of Lymphangioleiomyomatosis
淋巴管平滑肌瘤病的分子和生化基础
- 批准号:
8612928 - 财政年份:2014
- 资助金额:
$ 27.23万 - 项目类别:
Molecular and biochemical basis of Lymphangioleiomyomatosis
淋巴管平滑肌瘤病的分子和生化基础
- 批准号:
9197682 - 财政年份:2014
- 资助金额:
$ 27.23万 - 项目类别:
Development of a high content cell based screen for inhibitors of the mTOR signal
开发基于细胞的高含量 mTOR 信号抑制剂筛选
- 批准号:
7680763 - 财政年份:2007
- 资助金额:
$ 27.23万 - 项目类别:
Development of a high content cell based screen for inhibitors of the mTOR signal
开发基于细胞的高含量 mTOR 信号抑制剂筛选
- 批准号:
7290648 - 财政年份:2007
- 资助金额:
$ 27.23万 - 项目类别:
相似国自然基金
Research on Quantum Field Theory without a Lagrangian Description
- 批准号:24ZR1403900
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
Cell Research
- 批准号:31224802
- 批准年份:2012
- 资助金额:24.0 万元
- 项目类别:专项基金项目
Cell Research
- 批准号:31024804
- 批准年份:2010
- 资助金额:24.0 万元
- 项目类别:专项基金项目
Cell Research (细胞研究)
- 批准号:30824808
- 批准年份:2008
- 资助金额:24.0 万元
- 项目类别:专项基金项目
Research on the Rapid Growth Mechanism of KDP Crystal
- 批准号:10774081
- 批准年份:2007
- 资助金额:45.0 万元
- 项目类别:面上项目
相似海外基金
VIMORTP (Vanderbilt Integrated Molecular Oncology Research Training Program)
VIMORTP(范德比尔特综合分子肿瘤学研究培训计划)
- 批准号:
10225434 - 财政年份:2018
- 资助金额:
$ 27.23万 - 项目类别:
VIMORTP (Vanderbilt Integrated Molecular Oncology Research Training Program)
VIMORTP(范德比尔特综合分子肿瘤学研究培训计划)
- 批准号:
9981681 - 财政年份:2018
- 资助金额:
$ 27.23万 - 项目类别:
VIMORTP (Vanderbilt Integrated Molecular Oncology Research Training Program)
VIMORTP(范德比尔特综合分子肿瘤学研究培训计划)
- 批准号:
10449242 - 财政年份:2018
- 资助金额:
$ 27.23万 - 项目类别:
Molecular and Cellular Oncology Research Program
分子和细胞肿瘤学研究计划
- 批准号:
10712119 - 财政年份:2013
- 资助金额:
$ 27.23万 - 项目类别:
The UTSW Small Animal SPECT-CT for Molecular Imaging Research and Education
用于分子影像研究和教育的 UTSW 小动物 SPECT-CT
- 批准号:
7843162 - 财政年份:2010
- 资助金额:
$ 27.23万 - 项目类别:
The Terry Fox Foundation Strategic Health Research Training Program in Molecular Pathology of Cancer at CIHR
CIHR 特里福克斯基金会癌症分子病理学战略健康研究培训项目
- 批准号:
184287 - 财政年份:2008
- 资助金额:
$ 27.23万 - 项目类别:
Operating Grants
Molecular Biology and Therapeutics in Musculoskeletal Oncology (MBTMO) Research S
肌肉骨骼肿瘤学的分子生物学和治疗学 (MBTMO) 研究 S
- 批准号:
7541111 - 财政年份:2008
- 资助金额:
$ 27.23万 - 项目类别:
Research Project 1: Understanding the Molecular Evolution of Castration-Resistant Prostate Cancer
研究项目1:了解去势抵抗性前列腺癌的分子进化
- 批准号:
9148031 - 财政年份:2001
- 资助金额:
$ 27.23万 - 项目类别: